F.L. Putnam Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
2,074
-49
| -2% | -$6.2K | ﹤0.01% | 513 |
|
|
2025
Q1 | $272K | Buy |
2,123
+397
| +23% | +$50.8K | 0.01% | 506 |
|
|
2024
Q4 | $228K | Buy |
1,726
+9
| +0.5% | +$1.19K | ﹤0.01% | 532 |
|
|
2024
Q3 | $250K | Sell |
1,717
-9
| -0.5% | -$1.31K | ﹤0.01% | 523 |
|
|
2024
Q2 | $237K | Buy |
1,726
+224
| +15% | +$30.7K | ﹤0.01% | 515 |
|
|
2024
Q1 | $206K | Hold |
1,502
| – | – | ﹤0.01% | 466 |
|
|
2023
Q4 | $204K | Buy |
+1,502
| New | +$204K | ﹤0.01% | 459 |
|
|
2023
Q1 | – | Sell |
-1,755
| Closed | -$230K | – | 430 |
|
|
2022
Q4 | $230K | Sell |
1,755
-30
| -2% | -$3.94K | 0.01% | 378 |
|
|
2022
Q3 | $209K | Sell |
1,785
-298
| -14% | -$34.9K | 0.01% | 379 |
|
|
2022
Q2 | $245K | Buy |
2,083
+19
| +0.9% | +$2.24K | 0.01% | 362 |
|
|
2022
Q1 | $269K | Sell |
2,064
-135
| -6% | -$17.6K | 0.01% | 358 |
|
|
2021
Q4 | $336K | Sell |
2,199
-92
| -4% | -$14.1K | 0.01% | 325 |
|
|
2021
Q3 | $370K | Sell |
2,291
-69
| -3% | -$11.1K | 0.01% | 310 |
|
|
2021
Q2 | $386K | Sell |
2,360
-29
| -1% | -$4.74K | 0.01% | 309 |
|
|
2021
Q1 | $360K | Sell |
2,389
-360
| -13% | -$54.2K | 0.02% | 282 |
|
|
2020
Q4 | $416K | Sell |
2,749
-63
| -2% | -$9.53K | 0.02% | 245 |
|
|
2020
Q3 | $381K | Sell |
2,812
-727
| -21% | -$98.5K | 0.02% | 224 |
|
|
2020
Q2 | $484K | Buy |
3,539
+43
| +1% | +$5.88K | 0.03% | 208 |
|
|
2020
Q1 | $377K | Sell |
3,496
-219
| -6% | -$23.6K | 0.03% | 218 |
|
|
2019
Q4 | $448K | Sell |
3,715
-95
| -2% | -$11.5K | 0.03% | 221 |
|
|
2019
Q3 | $379K | Buy |
3,810
+2,127
| +126% | +$212K | 0.03% | 221 |
|
|
2019
Q2 | $184K | Sell |
1,683
-236
| -12% | -$25.8K | 0.01% | 225 |
|
|
2019
Q1 | $215K | Buy |
+1,919
| New | +$215K | 0.02% | 212 |
|